Part of the Series: From dietary antioxidants to regulators in cellular signaling and gene regulation

References

• Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 533–543
   PubMed Web of Science ®Google Scholar
• World Health Organization, International Agency for Research on Cancer (IARC). World Cancer Report, IARC Press, Lyon, France 2003
   Google Scholar
• WCRF/AICR. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition and the Prevention of Cancer: A global perspective 1997., Washington DC
   Google Scholar
• COMA. Report of the working group on diet and cancer. Nutritional aspects of the development of cancer, Stationery Office, London 1998
   Google Scholar
• Riboli E, Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 2003; 78: 559S–569S
   PubMed Web of Science ®Google Scholar
• van Gils CH, Peeters PH, Bueno-de-Mesquita HB, Boshuizen HC, Lahmann PH, Clavel-Chapelon F, Thiebaut A, Kesse E, Sieri S, Palli D, Tumino R, Panico S, Vineis P, Gonzalez CA, Ardanaz E, Sanchez MJ, Amiano P, Navarro C, Quiros JR, Key TJ, Allen N, Khaw KT, Bingham SA, Psaltopoulou T, Koliva M, Trichopoulou A, Nagel G, Linseisen J, Boeing H, Berglund G, Wirfalt E, Hallmans G, Lenner P, Overvad K, Tjonneland A, Olsen A, Lund E, Engeset D, Alsaker E, Norat T, Kaaks R, Slimani N, Riboli E. Consumption of vegetables and fruits and risk of breast cancer. JAMA 2005; 293: 183–193
   PubMed Web of Science ®Google Scholar
• Terry P, Giovannucci E, Michels KB, Bergkvist L, Hansen H, Holmberg L, Wolk A. Fruit, vegetables, dietary fiber, and risk of colorectal cancer. J Natl Cancer Inst 2001; 93: 525–533
   PubMed Web of Science ®Google Scholar
• Michaud DS, Clinton SK, Rimm EB, Willett WC, Giovannucci E. Risk of bladder cancer by geographic region in a U.S. cohort of male health professionals. Epidemiology 2001; 12: 719–726
   PubMed Web of Science ®Google Scholar
• Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Willett WC, Giovannucci EL. Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort. J Natl Cancer Inst 1999; 91: 605–613
   PubMed Web of Science ®Google Scholar
• Ambrosone CB, McCann SE, Freudenheim JL, Marshall JR, Zhang Y, Shields PG. Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype. J Nutr 2004; 134: 1134–1138
   PubMed Web of Science ®Google Scholar
• Verhoeven DT, Goldbohm RA, van Poppel G, Verhagen H, van den Brandt PA. Epidemiological studies on brassica vegetables and cancer risk. Cancer Epidemiol Biomarkers Prev 1996; 5: 733–748
   PubMed Web of Science ®Google Scholar
• Shamberger RJ, Frost DV. Possible protective effect of selenium against human cancer. Can Med Assoc J 1969; 682
   PubMed Web of Science ®Google Scholar
• Rayman MP. Selenium in cancer prevention: A review of the evidence and mechanism of action. Proc Nutr Soc 2005; 64: 527–542
   PubMed Web of Science ®Google Scholar
• Combs GF, Jr. Current evidence and research needs to support a health claim for selenium and cancer prevention. J Nutr 2005; 135: 343–347
   PubMed Web of Science ®Google Scholar
• Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL, Park HK, Sanders BB, Smith CL, Taylor JR. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin a randomized controlled trial—A randomized controlled trial. JAMA 1996; 276: 1957–1963
   PubMed Web of Science ®Google Scholar
• Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF, Jr., Slate EH, Fischbach LA, Marshall JR, Clark LC. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: A summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 2002; 11: 630–639
   PubMed Web of Science ®Google Scholar
• Corpet DE, Tache S. Most effective colon cancer chemopreventive agents in rats: A systematic review of aberrant crypt foci and tumor data, ranked by potency. Nutr Cancer 2002; 43: 1–21
   PubMed Web of Science ®Google Scholar
• Finley JW, Davis CD, Feng Y. Selenium from high selenium broccoli protects rats from colon cancer. J Nutr 2000; 130: 2384–2389
   PubMed Web of Science ®Google Scholar
• Finley JW, Ip C, Lisk DJ, Davis CD, Hintze KJ, Whanger PD. Cancer-protective properties of high-selenium broccoli. J Agric Food Chem 2001; 49: 2679–2683
   PubMed Web of Science ®Google Scholar
• Zhang J, Svehlikova V, Bao Y, Howie AF, Beckett GJ, Williamson G. Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation. Carcinogenesis 2003; 24: 497–503
   PubMed Web of Science ®Google Scholar
• Hintze KJ, Wald KA, Zeng H, Jeffery EH, Finley JW. Thioredoxin reductase in human hepatoma cells is transcriptionally regulated by sulforaphane and other electrophiles via an antioxidant response element. J Nutr 2003; 133: 2721–2727
   PubMed Web of Science ®Google Scholar
• Wang W, Wang S, Howie AF, Beckett GJ, Mithen R, Bao Y. Sulforaphane, erucin, and iberin up-regulate thioredoxin reductase 1 expression in human MCF-7 cells. J Agric Food Chem 2005; 53: 1417–1421
   PubMed Web of Science ®Google Scholar
• Banning A, Deubel S, Kluth D, Zhou Z, Brigelius-Flohé R. The GI-GPx gene is a target for Nrf2. Mol Cell Biol 2005; 25: 4914–4923
   PubMed Web of Science ®Google Scholar
• Rabot S, Nugon-Baudon L, Raibaud P, Szylit O. Rape-seed meal toxicity in gnotobiotic rats: Influence of a whole human faecal flora or single human strains of Escherichia coli and Bacteroides vulgatus. Br J Nutr 1993; 70: 323–331
   PubMed Web of Science ®Google Scholar
• Gamet-Payrastre L, Li P, Lumeau S, Cassar G, Dupont MA, Chevolleau S, Gasc N, Tulliez J, Terce F. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res 2000; 60: 1426–1433
   PubMed Web of Science ®Google Scholar
• Lee SK, Song L, Mata-Greenwood E, Kelloff GJ, Steele VE, Pezzuto JM. Modulation of in vitro biomarkers of the carcinogenic process by chemopreventive agents. Anticancer Res 1999; 19: 35–44
   PubMed Web of Science ®Google Scholar
• Jackson SJ, Singletary KW. Sulforaphane: A naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization. Carcinogenesis 2004; 25: 219–227
   PubMed Web of Science ®Google Scholar
• Myzak MC, Karplus PA, Chung FL, Dashwood RH. A novel mechanism of chemoprotection by sulforaphane: Inhibition of histone deacetylase. Cancer Res 2004; 64: 5767–5774
   PubMed Web of Science ®Google Scholar
• Myzak MC, Dashwood WM, Orner GA, Ho E, Dashwood RH. Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apcmin mice. FASEB J 2006
   PubMed Web of Science ®Google Scholar
• Heiss E, Herhaus C, Klimo K, Bartsch H, Gerhauser C. Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J Biol Chem 2001; 276: 32008–32015
   PubMed Web of Science ®Google Scholar
• Heiss E, Gerhauser C. Time-dependent modulation of thioredoxin reductase activity might contribute to sulforaphane-mediated inhibition of NF-kappaB binding to DNA. Antioxid Redox Signal 2005; 7: 1601–1611
   PubMed Web of Science ®Google Scholar
• Fahey JW, Talalay P. Antioxidant functions of sulforaphane: A potent inducer of Phase II detoxication enzymes. Food Chem Toxicol 1999; 37: 973–979
   PubMed Web of Science ®Google Scholar
• Xu C, Li CY, Kong AN. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res 2005; 28: 249–268
   PubMed Web of Science ®Google Scholar
• Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M, Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 1997; 236: 313–322
   PubMed Web of Science ®Google Scholar
• Ramos-Gomez M, Kwak MK, Dolan PM, Itoh K, Yamamoto M, Talalay P, Kensler TW. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in Nrf2 transcription factor-deficient mice. Proc Natl Acad Sci USA 2001; 98: 3410–3415
   PubMed Web of Science ®Google Scholar
• Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, Yamamoto M, Talalay P. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA 2002; 99: 11908–11913
   PubMed Web of Science ®Google Scholar
• Dinkova-Kostova AT, Holtzclaw WD, Wakabayashi N. Keap1, the sensor for electrophiles and oxidants that regulates the phase 2 response, is a zinc metalloprotein. Biochemistry 2005; 44: 6889–6899
   PubMed Web of Science ®Google Scholar
• Wakabayashi N, Dinkova-Kostova AT, Holtzclaw WD, Kang MI, Kobayashi A, Yamamoto M, Kensler TW, Talalay P. Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers. Proc Natl Acad Sci USA 2004; 101: 2040–2045
   PubMed Web of Science ®Google Scholar
• Lee JS, Surh YJ. Nrf2 as a novel molecular target for chemoprevention. Cancer Lett 2005; 224: 171–184
   PubMed Web of Science ®Google Scholar
• Itoh K, Wakabayashi N, Katoh Y, Ishii T, O'Connor T, Yamamoto M. Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells 2003; 8: 379–391
   PubMed Web of Science ®Google Scholar
• McMahon M, Itoh K, Yamamoto M, Hayes JD. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem 2003; 278: 21592–21600
   PubMed Web of Science ®Google Scholar
• Cullinan SB, Gordan JD, Jin J, Harper JW, Diehl JA. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: Oxidative stress sensing by a Cul3-Keap1 ligase. Mol Cell Biol 2004; 24: 8477–8486
   PubMed Web of Science ®Google Scholar
• Kobayashi A, Kang MI, Okawa H, Ohtsuji M, Zenke Y, Chiba T, Igarashi K, Yamamoto M. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 2004; 24: 7130–7139
   PubMed Web of Science ®Google Scholar
• Zhang DD, Lo SC, Cross JV, Templeton DJ, Hannink M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol Cell Biol 2004; 24: 10941–10953
   PubMed Web of Science ®Google Scholar
• Zhang DD, Lo SC, Sun Z, Habib GM, Lieberman MW, Hannink M. Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway. J Biol Chem 2005; 280: 30091–30099
   PubMed Web of Science ®Google Scholar
• Huang HC, Nguyen T, Pickett CB. Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2. Proc Natl Acad Sci USA 2000; 97: 12475–12480
   PubMed Web of Science ®Google Scholar
• Huang HC, Nguyen T, Pickett CB. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J Biol Chem 2002; 277: 42769–42774
   PubMed Web of Science ®Google Scholar
• Kang KW, Ryu JH, Kim SG. The essential role of phosphatidylinositol 3-kinase and of p38 mitogen-activated protein kinase activation in the antioxidant response element-mediated rGSTA2 induction by decreased glutathione in H4IIE hepatoma cells. Mol Pharmacol 2000; 58: 1017–1025
   PubMed Web of Science ®Google Scholar
• Nakaso K, Yano H, Fukuhara Y, Takeshima T, Wada-Isoe K, Nakashima K. PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells. FEBS Lett 2003; 546: 181–184
   PubMed Web of Science ®Google Scholar
• Görlich D, Kutay U. Transport between the cell nucleus and the cytoplasm. Annu Rev Cell Dev Biol 1999; 15: 607–660
   PubMed Web of Science ®Google Scholar
• Li W, Jain MR, Chen C, Yue X, Hebbar V, Zhou R, Kong AN. Nrf2 Possesses a redox-insensitive nuclear export signal overlapping with the leucine zipper motif. J Biol Chem 2005; 280: 28430–28438
   PubMed Web of Science ®Google Scholar
• Jain AK, Bloom DA, Jaiswal AK. Nuclear import and export signals in control of Nrf2. J Biol Chem 2005; 280: 29158–29168
   PubMed Web of Science ®Google Scholar
• Velichkova M, Hasson T. Keap1 regulates the oxidation-sensitive shuttling of Nrf2 into and out of the nucleus via a Crm1-dependent nuclear export mechanism. Mol Cell Biol 2005; 25: 4501–4513
   PubMed Web of Science ®Google Scholar
• Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 1999; 13: 76–86
   PubMed Web of Science ®Google Scholar
• Kobayashi A, Kang MI, Watai Y, Tong KI, Shibata T, Uchida K, Yamamoto M. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol Cell Biol 2006; 26: 221–229
   PubMed Web of Science ®Google Scholar
• Chen C, Kong AN. Dietary chemopreventive compounds and ARE/EpRE signaling. Free Radic Biol Med 2004; 36: 1505–1516
   PubMed Web of Science ®Google Scholar
• Prochaska HJ, De Long MJ, Talalay P. On the mechanisms of induction of cancer-protective enzymes: A uni fying proposal. Proc Natl Acad Sci USA 1985; 82: 8232–8236
   PubMed Web of Science ®Google Scholar
• Talalay P, De Long MJ, Prochaska HJ. Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis. Proc Natl Acad Sci USA 1988; 85: 8261–8265
   PubMed Web of Science ®Google Scholar
• Spencer SR, Xue LA, Klenz EM, Talalay P. The potency of inducers of NAD(P)H:(Quinone-acceptor) Oxidoreductase parallels their efficiency as substrates for glutathione transferases. Structural and electronic correlations. Biochem J 1991; 273: 711–717
   PubMed Web of Science ®Google Scholar
• Levonen AL, Landar A, Ramachandran A, Ceaser EK, Dickinson DA, Zanoni G, Morrow JD, Darley-Usmar VM. Cellular mechanisms of redox cell signalling: Role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem J 2004; 378: 373–382
   PubMed Web of Science ®Google Scholar
• Chiarugi P. PTPs versus PTKs: The redox side of the coin. Free Radic Res 2005; 39: 353–364
   PubMed Web of Science ®Google Scholar
• Ghezzi P. Regulation of protein function by glutathionylation. Free Radic Res 2005; 39: 573–580
   PubMed Web of Science ®Google Scholar
• O'Brian CA, Chu F. Post-translational disulfide modifications in cell signaling—role of inter-protein, intra-protein, S-glutathionyl, and S-cysteaminyl disulfide modifications in signal transmission. Free Radic Res 2005; 39: 471–480
   PubMed Web of Science ®Google Scholar
• Kim BR, Hu R, Keum YS, Hebbar V, Shen G, Nair SS, Kong AN. Effects of glutathione on antioxidant response element-mediated gene expression and apoptosis elicited by sulforaphane. Cancer Res 2003; 63: 7520–7525
   PubMed Web of Science ®Google Scholar
• Singh SV, Srivastava SK, Choi S, Lew KL, Antosiewicz J, Xiao D, Zeng Y, Watkins SC, Johnson CS, Trump DL, Lee YJ, Xiao H, Herman-Antosiewicz A. Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. J Biol Chem 2005; 280: 19911–19924
   PubMed Web of Science ®Google Scholar
• Brigelius-Flohé R, Maiorino M, Ursini F, Flohé L. Selenium: An antioxidant?. Handbook of antioxidants, E Cadenas, L Packer. Marcel Dekker, Inc, New York, Basel 2001; 633–664
   Google Scholar
• Hatfield DL, Gladyshev VN. How selenium has altered our understanding of the genetic code. Mol Cell Biol 2002; 22: 3565–3576
   PubMed Web of Science ®Google Scholar
• Small-Howard AL, Berry MJ. Unique features of selenocysteine incorporation function within the context of general eukaryotic translational processes. Biochem Soc Trans 2005; 33: 1493–1497
   PubMed Web of Science ®Google Scholar
• Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigó R, Gladyshev VN. Characterization of mammalian selenoproteomes. Science 2003; 300: 1439–1443
   PubMed Web of Science ®Google Scholar
• Brigelius-Flohé R. Tissue-specific functions of individual glutathione peroxidases. Free Radic Biol Med 1999; 27: 951–965
   PubMed Web of Science ®Google Scholar
• Köhrle J, Brigelius-Flohé R, Böck A, Gärtner R, Meyer O, Flohé L. Selenium in biology: Facts and medical perspectives. Biol Chem 2000; 381: 849–864
   PubMed Web of Science ®Google Scholar
• Flohé L, Brigelius-Flohé R. Selenoproteins of the glutathione system. Selenium: Its molecular biology and role in human health1st edition ed., DL Hatfield. Kluwer Academic Publishers, Boston, Dordrecht, London 2001; 157–178
   Google Scholar
• Flohé L, Brigelius-Flohé R. Selenoproteins of the glutathione system. Selenoproteins of the glutathione system2nd edition ed., DL Hatfield. Kluwer Academic Publishers, Boston, Dordrecht, London 2006, in press
   Google Scholar
• Ganther HE. Pathways of selenium metabolism including respiratory excretory products. J Am Coll Toxicol 1986; 5: 1–5
   Google Scholar
• Combs GF, Jr, Clark LC, Turnbull BW. An analysis of cancer prevention by selenium. Biofactors 2001; 14: 153–159
   PubMed Web of Science ®Google Scholar
• Xia Y, Hill KE, Byrne DW, Xu J, Burk RF. Effectiveness of selenium supplements in a low-selenium area of China. Am J Clin Nutr 2005; 81: 829–834
   PubMed Web of Science ®Google Scholar
• Gromer S, Urig S, Becker K. The thioredoxin system—from science to clinic. Med Res Rev 2004; 24: 40–89
   PubMed Web of Science ®Google Scholar
• Zhong L, Arner ES, Ljung J, Aslund F, Holmgren A. Rat and calf thioredoxin reductase are homologous to glutathione reductase with a carboxyl-terminal elongation containing a conserved catalytically active penultimate selenocysteine residue. J Biol Chem 1998; 273: 8581–8591
   PubMed Web of Science ®Google Scholar
• Holmgren A. Thioredoxin. Annu Rev Biochem 1985; 54: 237–271
   PubMed Web of Science ®Google Scholar
• Raffel J, Bhattacharyya AK, Gallegos A, Cui H, Einspahr JG, Alberts DS, Powis G. Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival. J Lab Clin Med 2003; 142: 46–51
   PubMed Web of Science ®Google Scholar
• Berggren M, Gallegos A, Gasdaska JR, Gasdaska PY, Warneke J, Powis G. Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia. Anticancer Res 1996; 16: 3459–3466
   PubMed Web of Science ®Google Scholar
• Lincoln DT, Ali Emadi EM, Tonissen KF, Clarke FM. The thioredoxin–thioredoxin reductase system: Over-expression in human cancer. Anticancer Res 2003; 23: 2425–2433
   PubMed Web of Science ®Google Scholar
• Bjorkhem L, Teclebrhan H, Kesen E, Olsson JM, Eriksson LC, Bjornstedt M. Increased levels of cytosolic thioredoxin reductase activity and mRNA in rat liver nodules. J Hepatol 2001; 35: 259–264
   PubMed Web of Science ®Google Scholar
• Becker K, Gromer S, Schirmer RH, Muller S. Thioredoxin reductase as a pathophysiological factor and drug target. Eur J Biochem 2000; 267: 6118–6125
   PubMedGoogle Scholar
• Fang J, Lu J, Holmgren A. Thioredoxin reductase is irreversibly modified by curcumin: A novel molecular mechanism for its anticancer activity. J Biol Chem 2005; 280: 25284–25290
   PubMed Web of Science ®Google Scholar
• Witte AB, Anestal K, Jerremalm E, Ehrsson H, Arner ES. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds. Free Radic Biol Med 2005; 39: 696–703
   PubMed Web of Science ®Google Scholar
• Lechner S, Muller-Ladner U, Neumann E, Spottl T, Schlottmann K, Ruschoff J, Scholmerich J, Kullmann F. Thioredoxin reductase 1 expression in colon cancer: Discrepancy between in vitro and in vivo findings. Lab Invest 2003; 83: 1321–1331
   PubMed Web of Science ®Google Scholar
• Nalvarte I, Damdimopoulos AE, Nystom C, Nordman T, Miranda-Vizuete A, Olsson JM, Eriksson L, Bjornstedt M, Arner ES, Spyrou G. Overexpression of enzymatically active human cytosolic and mitochondrial thioredoxin reductase in HEK-293 cells. Effect on cell growth and differentiation. J Biol Chem 2004; 279: 54510–54517
   PubMed Web of Science ®Google Scholar
• Streicher KL, Sylte MJ, Johnson SE, Sordillo LM. Thioredoxin reductase regulates angiogenesis by increasing endothelial cell-derived vascular endothelial growth factor. Nutr Cancer 2004; 50: 221–231
   PubMed Web of Science ®Google Scholar
• Park YS, Misonou Y, Fujiwara N, Takahashi M, Miyamoto Y, Koh YH, Suzuki K, Taniguchi N. Induction of thioredoxin reductase as an adaptive response to acrolein in human umbilical vein endothelial cells. Biochem Biophys Res Commun 2005; 327: 1058–1065
   PubMed Web of Science ®Google Scholar
• Stewart D, Killeen E, Naquin R, Alam S, Alam J. Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium. J Biol Chem 2003; 278: 2396–2402
   PubMed Web of Science ®Google Scholar
• Sakurai A, Nishimoto M, Himeno S, Imura N, Tsujimoto M, Kunimoto M, Hara S. Transcriptional regulation of thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: Role of NF-E2-related factor-2. J Cell Physiol 2005; 203: 529–537
   PubMed Web of Science ®Google Scholar
• Kim YC, Yamaguchi Y, Kondo N, Masutani H, Yodoi J. Thioredoxin-dependent redox regulation of the antioxidant responsive element (ARE) in electrophile response. Oncogene 2003; 22: 1860–1865
   PubMed Web of Science ®Google Scholar
• Serewko MM, Popa C, Dahler AL, Smith L, Strutton GM, Coman W, Dicker AJ, Saunders NA. Alterations in gene expression and activity during squamous cell carcinoma development. Cancer Res 2002; 62: 3759–3765
   PubMed Web of Science ®Google Scholar
• Florian S, Wingler K, Schmehl K, Jacobasch G, Kreuzer OJ, Meyerhof W, Brigelius-Flohé R. Cellular and subcellular localization of gastrointestinal glutathione peroxidase in normal and malignant human intestinal tissue. Free Rad Res 2001; 35: 655–663
   PubMed Web of Science ®Google Scholar
• Esworthy RS, Mann JR, Sam M, Chu FF. Low glutathione peroxidase activity in Gpx1 knockout mice protects jejunum crypts from gamma-irradiation damage. Am J Physiol Gastrointest Liver Physiol 2000; 279: G426–G436
   PubMed Web of Science ®Google Scholar
• Esworthy RS, Aranda R, Martin MG, Doroshow JH, Binder SW, Chu FF. Mice with combined disruption of Gpx1 and Gpx2 genes have colitis. Am J Physiol Gastrointest Liver Physiol 2001; 281: G848–G855
   PubMed Web of Science ®Google Scholar
• Chu FF, Esworthy RS, Chu PG, Longmate JA, Huycke MM, Wilczynski S, Doroshow JH. Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes. Cancer Res 2004; 64: 962–968
   PubMed Web of Science ®Google Scholar
• Esworthy RS, Binder SW, Doroshow JH, Chu F. Microflora trigger colitis in mice deficient in selenium-dependent glutathione peroxidase and induce Gpx2 gene expression. Biol Chem 2003; 384: 597–607
   PubMed Web of Science ®Google Scholar
• Chu FF, Esworthy RS, Lee L, Wilczynski S. Retinoic acid induces Gpx2 gene expression in MCF-7 human breast cancer cells. J Nutr 1999; 129: 1846–1854
   PubMed Web of Science ®Google Scholar
• Morbitzer M, Herget T. Expression of gastrointestinal glutathione peroxidase is inversely correlated to the presence of hepatitis C virus subgenomic RNA in human liver cells. J Biol Chem 2005; 280: 8831–8841
   PubMed Web of Science ®Google Scholar
• Thimmulappa RK, Mai KH, Srisuma S, Kensler TW, Yamamoto M, Biswal S. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 2002; 62: 5196–5203
   PubMed Web of Science ®Google Scholar
• Cho HY, Reddy SP, Debiase A, Yamamoto M, Kleeberger SR. Gene expression profiling of NRF2-mediated protection against oxidative injury. Free Radic Biol Med 2005; 38: 325–343
   PubMed Web of Science ®Google Scholar
• Kelner MJ, Bagnell RD, Montoya MA, Lanham KA. Structural organization of the human gastrointestinal glutathione peroxidase (GPX2) promoter and 3'-nontranscribed region: Transcriptional response to exogenous redox agents. Gene 2000; 248: 109–116
   PubMed Web of Science ®Google Scholar
• Wingler K, Böcher M, Flohé L, Kollmus H, Brigelius-Flohé R. mRNA stability and selenocysteine insertion sequence efficiency rank gastrointestinal glutathione peroxidase high in the hierarchy of selenoproteins. Eur J Biochem 1999; 259: 149–157
   PubMedGoogle Scholar
• Esworthy RS, Yang L, Frankel PH, Chu FF. Epithelium-specific glutathione peroxidase, Gpx2, is involved in the prevention of intestinal inflammation in selenium-deficient mice. J Nutr 2005; 135: 740–745
   PubMed Web of Science ®Google Scholar
• Chu FF, Esworthy RS, Doroshow JH. Role of Se-dependent glutathione peroxidases in gastrointestinal inflammation and cancer. Free Radic Biol Med 2004; 36: 1481–1495
   PubMed Web of Science ®Google Scholar
• Balkwill F, Mantovani A. Inflammation and cancer: Back to Virchow?. Lancet 2001; 357: 539–545
   PubMed Web of Science ®Google Scholar
• Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF, Karin M. IKK beta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004; 118: 285–296
   PubMed Web of Science ®Google Scholar
• Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, Ben-Neriah Y. NF-kappa B functions as a tumour promoter in inflammation-associated cancer. Nature 2004; 431: 461–466
   PubMed Web of Science ®Google Scholar
• Karin M. Inflammation and cancer: The long reach of Ras. Nat Med 2005; 11: 20–21
   PubMed Web of Science ®Google Scholar
• Maeda S, Kamata H, Luo JL, Leffert H, Karin M. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005; 121: 977–990
   PubMed Web of Science ®Google Scholar
• Gupta RA, DuBois RN. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nature Rev 2001; 1: 11–21
   Web of Science ®Google Scholar
• Wallace JM. Nutritional and botanical modulation of the inflammatory cascade - eicosanoids, cyclooxygenases, and lipoxygenases—as an adjunct in cancer therapy. Integr Cancer Ther 2002; 1: 7–37
   PubMedGoogle Scholar
• Heirman I, Ginneberge D, Brigelius-Flohe R, Hendrickx N, Agostinis P, Brouckaert P, Rottiers P, Grooten J. Blocking tumor cell eicosanoid synthesis by GPx4 impedes tumor growth and malignancy. Free Radic Biol Med 2006; 40: 285–294
   PubMed Web of Science ®Google Scholar
• Davis CD, Zeng H, Finley JW. Selenium-enriched broccoli decreases intestinal tumorigenesis in multiple intestinal neoplasia mice. J Nutr 2002; 132: 307–309
   PubMed Web of Science ®Google Scholar
• Keck AS, Finley JW. Aqueous extracts of selenium-fertilized broccoli increase selenoprotein activity and inhibit DNA single-strand breaks, but decrease the activity of quinone reductase in Hepa 1c1c7 cells. Food Chem Toxicol 2005
   PubMed Web of Science ®Google Scholar
• Robbins RJ, Keck AS, Banuelos G, Finley JW. Cultivation conditions and selenium fertilization alter the phenolic profile, glucosinolate, and sulforaphane content of broccoli. J Med Food 2005; 8: 204–214
   PubMed Web of Science ®Google Scholar
• Spallholz JE. On the nature of selenium toxicity and carcinostatic activity. Free Radic Biol Med 1994; 17: 45–64
   PubMed Web of Science ®Google Scholar
• Cha YN, Heine HS. Comparative effects of dietary administration of 2(3)-tert-butyl-4-hydroxyanisole and 3,5-di-tert-butyl-4-hydroxytoluene on several hepatic enzyme activities in mice and rats. Cancer Res 1982; 42: 2609–2615
   PubMed Web of Science ®Google Scholar
• Ellis EM, Slattery CM, Hayes JD. Characterization of the rat aflatoxin B1 aldehyde reductase gene, AKR7A1. Structure and chromosomal localization of AKR7A1 as well as identification of antioxidant response elements in the gene promoter. Carcinogenesis 2003; 24: 727–737
   PubMed Web of Science ®Google Scholar
• Benson AM, Cha YN, Bueding E, Heine HS, Talalay P. Elevation of extrahepatic glutathione S-transferase and epoxide hydratase activities by 2(3)-tert-butyl-4-hydroxyanisole. Cancer Res 1979; 39: 2971–2977
   PubMed Web of Science ®Google Scholar
• Benson AM, Batzinger RP, Ou SY, Bueding E, Cha YN, Talalay P. Elevation of hepatic glutathione S-transferase activities and protection against mutagenic metabolites of benzo(a)pyrene by dietary antioxidants. Cancer Res 1978; 38: 4486–4495
   PubMed Web of Science ®Google Scholar
• Benson AM, Hunkeler MJ, Talalay P. Increase of NAD(P)H:quinone reductase by dietary antioxidants: Possible role in protection against carcinogenesis and toxicity. Proc Natl Acad Sci USA 1980; 77: 5216–5220
   PubMed Web of Science ®Google Scholar
• Prestera T, Holtzclaw WD, Zhang Y, Talalay P. Chemical and molecular regulation of enzymes that detoxify carcinogens. Proc Natl Acad Sci USA 1993; 90: 2965–2969
   PubMed Web of Science ®Google Scholar
• Alam J, Camhi S, Choi AM. Identification of a second region upstream of the mouse heme oxygenase-1 gene that functions as a basal level and inducer-dependent transcription enhancer. J Biol Chem 1995; 270: 11977–11984
   PubMed Web of Science ®Google Scholar
• Prestera T, Talalay P. Electrophile and antioxidant regulation of enzymes that detoxify carcinogens. Proc Natl Acad Sci USA 1995; 92: 8965–8969
   PubMed Web of Science ®Google Scholar
• Ishii T, Itoh K, Takahashi S, Sato H, Yanagawa T, Katoh Y, Bannai S, Yamamoto M. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 2000; 275: 16023–16029
   PubMed Web of Science ®Google Scholar
• Ishii T, Itoh K, Ruiz E, Leake DS, Unoki H, Yamamoto M, Mann GE. Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: Activation by oxidatively modified LDL and 4-hydroxynonenal. Circ Res 2004; 94: 609–616
   PubMed Web of Science ®Google Scholar
• Primiano T, Kensler TW, Kuppusamy P, Zweier JL, Sutter TR. Induction of hepatic heme oxygenase-1 and ferritin in rats by cancer chemopreventive dithiolethiones. Carcinogenesis 1996; 17: 2291–2296
   PubMed Web of Science ®Google Scholar
• Pietsch EC, Chan JY, Torti FM, Torti SV. Nrf2 mediates the induction of ferritin H in response to xenobiotics and cancer chemopreventive dithiolethiones. J Biol Chem 2003; 278: 2361–2369
   PubMed Web of Science ®Google Scholar
• Ciaccio PJ, Jaiswal AK, Tew KD. Regulation of human dihydrodiol dehydrogenase by Michael acceptor xenobiotics. J Biol Chem 1994; 269: 15558–15562
   PubMed Web of Science ®Google Scholar
• Sherratt PJ, McLellan LI, Hayes JD. Positive and negative regulation of prostaglandin E2 biosynthesis in human colorectal carcinoma cells by cancer chemopreventive agents. Biochem Pharmacol 2003; 66: 51–61
   PubMed Web of Science ®Google Scholar
• Moinova HR, Mulcahy RT. An electrophile responsive element (EpRE) regulates beta-naphthoflavone induction of the human gamma-glutamylcysteine synthetase regulatory subunit gene. Constitutive expression is mediated by an adjacent AP-1 site. J Biol Chem 1998; 273: 14683–14689
   PubMed Web of Science ®Google Scholar
• Sasaki H, Sato H, Kuriyama-Matsumura K, Sato K, Maebara K, Wang H, Tamba M, Itoh K, Yamamoto M, Bannai S. Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J Biol Chem 2002; 277: 44765–44771
   PubMed Web of Science ®Google Scholar
• Primiano T, Li Y, Kensler TW, Trush MA, Sutter TR. Identification of dithiolethione-inducible gene-1 as a leukotriene B4 12-hydroxydehydrogenase: Implications for chemoprevention. Carcinogenesis 1998; 19: 999–1005
   PubMed Web of Science ®Google Scholar
• Primiano T, Kensler TW, Trush MA, Sutter TR. Induction of leukotriene B4 metabolism by cancer chemopreventive agents. Adv Exp Med Biol 1999; 469: 599–605
   PubMed Web of Science ®Google Scholar
• Iida K, Itoh K, Kumagai Y, Oyasu R, Hattori K, Kawai K, Shimazui T, Akaza H, Yamamoto M. Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis. Cancer Res 2004; 64: 6424–6431
   PubMed Web of Science ®Google Scholar
• Dinkova-Kostova AT, Massiah MA, Bozak RE, Hicks RJ, Talalay P. Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc Natl Acad Sci USA 2001; 98: 3404–3409
   PubMed Web of Science ®Google Scholar
• Ben-Dor A, Steiner M, Gheber L, Danilenko M, Dubi N, Linnewiel K, Zick A, Sharoni Y, Levy J. Carotenoids activate the antioxidant response element transcription system. Mol Cancer Ther 2005; 4: 177–186
   PubMed Web of Science ®Google Scholar
• Chen C, Yu R, Owuor ED, Kong AN. Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch Pharm Res 2000; 23: 605–612
   PubMed Web of Science ®Google Scholar
• Chen XL, Varner SE, Rao AS, Grey JY, Thomas S, Cook CK, Wasserman MA, Medford RM, Jaiswal AK, Kunsch C. Laminar flow induction of antioxidant response element-mediated genes in endothelial cells. A novel anti-inflammatory mechanism. J Biol Chem 2003; 278: 703–711
   PubMed Web of Science ®Google Scholar
• Cullinan SB, Diehl JA. PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress. J Biol Chem 2004; 279: 20108–20117
   PubMed Web of Science ®Google Scholar
• Kim YC, Masutani H, Yamaguchi Y, Itoh K, Yamamoto M, Yodoi J. Hemin-induced activation of the thioredoxin gene by Nrf2. A differential regulation of the antioxidant responsive element by a switch of its binding factors. J Biol Chem 2001; 276: 18399–18406
   PubMed Web of Science ®Google Scholar
• Itoh K, Mochizuki M, Ishii Y, Ishii T, Shibata T, Kawamoto Y, Kelly V, Sekizawa K, Uchida K, Yamamoto M. Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin J2. Mol Cell Biol 2004; 24: 36–45
   PubMed Web of Science ®Google Scholar